Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- PMID: 29166236
- DOI: 10.1056/NEJMra1503519
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Comment in
-
Nonalcoholic Steatohepatitis.N Engl J Med. 2018 Feb 22;378(8):779-80. doi: 10.1056/NEJMc1716786. N Engl J Med. 2018. PMID: 29470010 No abstract available.
-
Nonalcoholic Steatohepatitis.N Engl J Med. 2018 Feb 22;378(8):780. doi: 10.1056/NEJMc1716786. N Engl J Med. 2018. PMID: 29470011 No abstract available.
-
Nonalcoholic Steatohepatitis.N Engl J Med. 2018 Feb 22;378(8):780. doi: 10.1056/NEJMc1716786. N Engl J Med. 2018. PMID: 29470012 No abstract available.
-
Nonalcoholic Steatohepatitis.N Engl J Med. 2018 Feb 22;378(8):780-1. doi: 10.1056/NEJMc1716786. N Engl J Med. 2018. PMID: 29470013 No abstract available.
Similar articles
-
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".World J Gastroenterol. 2018 Jul 21;24(27):2974-2983. doi: 10.3748/wjg.v24.i27.2974. World J Gastroenterol. 2018. PMID: 30038464 Free PMC article. Review.
-
Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.Surg Pathol Clin. 2018 Jun;11(2):267-285. doi: 10.1016/j.path.2018.02.013. Surg Pathol Clin. 2018. PMID: 29751874 Review.
-
The liver's weighty problem.Science. 2015 Jul 3;349(6243):18-20. doi: 10.1126/science.349.6243.18. Science. 2015. PMID: 26138960 No abstract available.
-
Pediatric Non-alcoholic Fatty Liver Disease.Curr Gastroenterol Rep. 2016 May;18(5):24. doi: 10.1007/s11894-016-0498-9. Curr Gastroenterol Rep. 2016. PMID: 27086005 Review.
-
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633. World J Gastroenterol. 2024. PMID: 38855152 Free PMC article.
Cited by
-
How improvements in US FDA regulatory process and procedures led to the drug approval for first ever treatment of a common liver disease.Acta Pharmacol Sin. 2024 Nov 7. doi: 10.1038/s41401-024-01396-4. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39511464
-
The AMPK-mTOR Pathway Is Inhibited by Chaihu Shugan Powder, Which Relieves Nonalcoholic Steatohepatitis by Suppressing Autophagic Ferroptosis.Mediators Inflamm. 2024 Oct 28;2024:4777789. doi: 10.1155/2024/4777789. eCollection 2024. Mediators Inflamm. 2024. PMID: 39502754 Free PMC article.
-
Liver Cancer and Risk Factors in the MENA Region: Epidemiology and Temporal Trends Based on the 2019 Global Burden of Disease Data.Cancer Control. 2024 Jan-Dec;31:10732748241297346. doi: 10.1177/10732748241297346. Cancer Control. 2024. PMID: 39487107 Free PMC article.
-
Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases.Sci Rep. 2024 Oct 14;14(1):24024. doi: 10.1038/s41598-024-74841-3. Sci Rep. 2024. PMID: 39402185 Free PMC article.
-
Ubiquitin-specific peptidase 25 ameliorates hepatic steatosis by stabilizing peroxisome proliferator-activated receptor alpha.J Biol Chem. 2024 Oct 11;300(11):107876. doi: 10.1016/j.jbc.2024.107876. Online ahead of print. J Biol Chem. 2024. PMID: 39395794 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical